Prevention of Early Alzheimer’s Disease by Erinacine A-Enriched Hericium erinaceus Mycelia Pilot Double-Blind Placebo-Controlled Study

OBJECTIVE: To investigate the efficacy and safety of three H. erinaceus mycelia (EAHE) capsules (350 mg/capsule; containing 5 mg/g erinacine A active ingredient) per day for the treatment of patients with mild Alzheimer’s Disease (AD). METHODS: This study comprised a 3-week no-drug screening period,...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, I-Chen, Chang, Han-Hsin, Lin, Chuan-Han, Chen, Wan-Ping, Lu, Tsung-Han, Lee, Li-Ya, Chen, Yu-Wen, Chen, Yen-Po, Chen, Chin-Chu, Lin, David Pei-Cheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Neuroscience
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7283924/
https://www.ncbi.nlm.nih.gov/pubmed/32581767
http://dx.doi.org/10.3389/fnagi.2020.00155

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7283924/
https://www.ncbi.nlm.nih.gov/pubmed/32581767
http://dx.doi.org/10.3389/fnagi.2020.00155

Ejemplares similares